FORM DEF 14A

Company

INTEGRATED BIOPHARMA INC

Filed

October 27, 2022

Period of Report

November 28, 2022

Accession Number

0001437749-22-024952

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →